About

Justin Gandhi leads The Argyle Group’s Advisory and Research Services line of business. He partners with clients to design and execute robust programs to capture market sentiment through qualitative and quantitative insights. Justin joined Argyle from Gerson Lehrman Group (GLG), where he led due diligence efforts on behalf of leading private equity firms and investment banks. Justin’s work with private equity firms and their portfolio companies spanned commercial due diligence, growth strategy, and M&A-strategy consulting.

While with GLG, he also worked in the hedge fund practice, for which he partnered with Portfolio Managers to guide healthcare and life sciences focused investment strategies.

Justin began his career in medicine, performing pre-clinical gene therapy and gene editing research at the University of Pennsylvania School of Medicine using novel CRISPR/Cas9 technology.

When he's not consuming content of all things related to modern finance, investing, and biotech - he can be found planning his next adventure, trying new restaurants, and involved in efforts to empower others through social impact.